The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

THE USE OF CHLORPROMAZINE HYDROCHLORIDE IN THE TREATMENT OF BARBITURATE ADDICTION WITH ACUTE WITHDRAWAL SYNDROME

Published Online:https://doi.org/10.1176/ajp.111.9.696

A patient with barbiturate addiction and the acute withdrawal syndrome was treated successfully with Thorazine. We feel this drug warrants further clinical investigation in the treatment of drug addiction.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.